Medtronic announced results from a survey indicating that AI and VR could help reduce disparities in access to surgical ...

Medtronic is a compelling investment with its diverse revenue streams, strong growth, and promising product pipeline at an ...

Across the healthcare landscape, more and more conversations are focusing on health inequity. Specific to pulse oximetry, recent research, media, and regulatory discussions have been raising awareness ...

it becomes less expensive for hospitals and companies that buy Medtronic's devices to finance them. That can help give its growth rate a bit of a boost. While Medtronic's revenue has been growing ...

We recently compiled a list of 10 Stocks That Will Change the World. In this article, we are going to take a look at where Medtronic plc (NYSE:MDT) stands against the other stocks. If we were to try ...

Medtronic (NYSE:MDT) said it has voluntarily recalled its MiniMed 600 and 700 series insulin pumps over reports of shortened battery life. The medical device maker said an investigation into the ...

Sept 19 (Reuters) - Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's (MDT.N), opens new tab patent rights in nerve ...

However, to ensure uninterrupted inhibition of therapy, care must be exercised to maintain proper magnet positioning over the implanted device. St. Jude Medical and Medtronic were also asked about ...

California medical device company Axonics has won its patent infringement trial after Medtronic alleged the company had copied three elements of its sacral neuromodulation technology. The lawsuit ...

Nico Chen has given his Hold rating due to a combination of factors affecting Medtronic’s financial stability and market position. The company, a global leader in medical devices, is facing ...

Medtronic VP Mike Marinaro details the 'full, holistic approach' of the newly combined surgical robotics, devices unit Using the company’s Hugo robot, Porter was scheduled to perform a live ...

Analyst Josh Jennings from TD Cowen maintained a Buy rating on Medtronic (MDT – Research Report) and keeping the price target at $95.00.